Global Ganja Report

After a one-year hiatus for just the second time since 1973 (the other being the pandemic year of 2020), New York City's Cannabis Parade returned to Lower Manhattan on May 3. The event had become increasingly mainstream in recent years, even drawing big-name politicians—like Sen. Chuck Schumer in 2021 and '22. The next year, the NYC Department of Small Business Services' new cannabis office issued a statement marking the event's 50th anniversary, and paying homage to its Yippie founders! The year after that, 2024, the City became an official partner in the event. But in 2025, the City would not grant a permit for either Washington Square Park or Union Square, the two traditional locations, and instead held a more commercialized NYC Cannabis Festival & Resource Fair outside the Harlem State Office Building on 125th Street. This year, however, downtown activists succeeded in getting a permit for a rally in Washington Square and march to Union Square, where a concert was held featuring the punk-reggae-hip-hop fusion bands Ricanstruction and Rebelmatic. The adversarial spirit, in spite of New York's legalization, brought the event back to its radical roots.

The Justice Department and Drug Enforcement Administration announced April 23 that FDA-approved marijuana products and medical marijuana products covered by a qualifying state-issued license have been moved to Schedule III of the Controlled Substances Act, a significant loosening of federal restrictions on the drug for medical use.

The order, issued by Acting Attorney General Todd Blanche, carries out President Donald Trump's Dec. 18, 2025 executive order calling for expanded research into medical marijuana and cannabidiol.

President Donlad Trump on April 18 signed an executive order calling on the DEA and FDA to open legal pathways for research into the therapeutic benefits of certain Schedule I psychedelic drugs—prominently including ibogaine, with an emphasis on its potential to treat PTSD in military veterans. The order instructs the FDA to collaborate with the Department of Veterans Affairs and the private sector "to increase clinical trial participation and evidence generation surrounding experimental psychedelic therapies." 

"Diamond" Dave Whitaker, a local legend and longtime counterculture figure in San Francisco, died March 2 at the age of 88. Long known as the "mayor of Haight Street," Whitaker was an organizer of underground poetry readings, pirate radio broadcasts, and countless other hippie-spirited events, keeping alive the flame of the city's vibrant 1960s scene for new generations of youth.

"Country Joe” McDonald of the band Country Joe & the Fish, immortalized as an icon of the 1960s counterculture through his proudly subversive performance at the Woodstock festival, died March 7 at his home in Berkeley, Calif. He was 84. In the defining moment of his career, he led a crowd of nearly half a million at the 1969 Upstate New York mega-concert in the "Fish Cheer" (spelling out the word FUCK) before launching into his satirical anti-war anthem "I-Feel-Like-I’m-Fixin'-to-Die Rag."

Bob Weir, who helped define the sound of the Grateful Dead, flagship band of the 1960s San Francisco scene, died Jan. 10 at the age of 78. His life was synonymous with the Dead, which he saw through its various incarnations—from its early roots in the Bay Area folk revival and bluegrass circuit to preeminent symbol of the youth counterculture, to an American institution and grand-daddies of the "jam band" tradition.

US air-strikes on so-called "drug boats" have now destroyed 30 vessels and killed more than 100 people in the Caribbean and eastern Pacific. And on Dec. 26, President Donald Trump boasted in a radio interview that the United States had knocked out "a big facility"—implying that it was a drug-trafficking hub on the Venezuelan mainland, although he provided no details and neither the White House, Pentagon nor US intelligence agencies would comment.

President Donald Trump signed an executive order Dec. 18 to accelerate the reclassification of marijuana, a move that would ease decades-old restrictions that have classified the drug alongside heroin as having no accepted medical value.

The US Controlled Substances Act ranks drugs along a five-tier spectrum based on their potential for abuse and recognized medical value. Schedule I drugs are those with a high likelihood of abuse, no accepted medical use, and considerable health risks even when administered under medical supervision. Since 1970, marijuana has been listed alongside heroin as a Schedule I drug. Schedule V drugs are those with accepted medical uses and a relatively low likelihood of abuse.